Clinical overview
Fetal monitoring is the art of inferring an invisible patient's wellbeing from indirect signals — and the central skill is not knowing how each test works but knowing which test answers which question, what each can and cannot tell you, and how the answer changes management. No single method is "best": each trades sensitivity against specificity, cost against availability, and the chronic question ("is this placenta failing over days to weeks?") against the acute question ("is this fetus coping with labour right now?"). The competence here is comparing the methods and matching each to the clinical question and the level of care.
The hard truth running through all of it is that most fetal monitoring tests are good at ruling out compromise (high negative predictive value, reassuring you) and poor at ruling it in (low positive predictive value, lots of false alarms). The cardiotocograph (CTG) is the classic example: a normal trace is genuinely reassuring, but an abnormal trace mostly reflects a healthy fetus mounting a normal reflex response, not impending death. This asymmetry is why monitoring done indiscriminately on low-risk women causes harm — it drives caesareans and instrumental births without reducing cerebral palsy or perinatal death — while the same tool, applied to the right high-risk fetus, is genuinely protective. In the South African context, where the NDoH National Integrated Maternal and Perinatal Care Guideline (NDoH, 2024) governs practice, and where intrapartum hypoxia and antepartum stillbirth remain major contributors to perinatal mortality (per the Saving Mothers / NCCEMD and perinatal-care surveillance), choosing and interpreting these tests correctly is a life-and-death registrar competency.
Core knowledge
The two clinical questions
Antenatal and intrapartum monitoring answer fundamentally different questions, and confusing them leads to the wrong test at the wrong moment.
- Antenatal: Is chronic uteroplacental insufficiency present, and is the fetus deteriorating over days to weeks? The threats are placental insufficiency, growth restriction and chronic hypoxia. You have time; you are surveilling.
- Intrapartum: Is the fetus tolerating the acute, repetitive hypoxic stress of contractions over minutes to hours? Each contraction transiently reduces placental perfusion; a fetus with reserve copes, one without reserve decompensates. You are watching for acute decompensation in real time.
The physiology underpinning both is covered in Contractions fetal oxygenation and Placental insufficiency response; the fetal compensatory cascade — redistribution of blood to brain, heart and adrenals ("brain-sparing"), then loss of that compensation — is what every test is trying to detect at successively later or earlier stages.
Figure I16.1 — Monitoring-method map matching antenatal and intrapartum tests to the clinical question, risk status and level of care.
Antenatal methods compared
Maternal perception of fetal movements is the cheapest, most universal "monitor" and the one most relevant at primary-care level. It costs nothing, needs no equipment, and a sudden reduction is a recognised harbinger of stillbirth. Its weakness is poor specificity and reliance on maternal report; formal "kick-count" charts have not been shown to reduce stillbirth in trials and are not mandated, but any woman reporting reduced fetal movements (RFM) warrants assessment (see Decreased fetal movements and RCOG GTG 57).
Symphysis-fundal height (SFH) measurement with a plotted growth chart is the antenatal screening backbone in low-resource settings. It is cheap and ubiquitous but operator-dependent and insensitive (it detects perhaps half of small-for-gestational-age fetuses). A static or falling SFH is a trigger to escalate to ultrasound, not an endpoint in itself.
Ultrasound biometry (estimated fetal weight, abdominal circumference) is the reference standard for detecting the small fetus and distinguishing constitutionally small from growth-restricted (see Intrauterine growth restriction and RCOG GTG 31). It diagnoses the problem but does not by itself time delivery — for that you need the dynamic tests below.
Doppler velocimetry is the pivotal antenatal surveillance tool in the growth-restricted fetus. Umbilical artery Doppler reflects placental resistance: rising resistance, then absent, then reversed end-diastolic flow marks worsening placental failure and is the only fetal test repeatedly shown to reduce perinatal death in high-risk (FGR) pregnancies. Middle cerebral artery (MCA) Doppler detects brain-sparing redistribution; a falling cerebroplacental ratio (CPR) is an earlier sign in late-onset FGR. Ductus venosus (DV) Doppler is a late, ominous sign reflecting cardiac decompensation and helps time delivery in early-onset FGR. The integrated use of these — and the ISUOG Doppler standards — is summarised below.
Biophysical profile (BPP) combines a CTG with four ultrasound parameters (fetal breathing, gross movement, tone, amniotic fluid volume), each scored 0 or 2 (max 10). It integrates acute markers (the first three are reflexes lost early in hypoxia) with a chronic marker (oligohydramnios reflects sustained redistribution away from the kidneys — see Liquor volume abnormalities). It is resource- and time-intensive and its routine use is not supported by strong outcome trials, so in practice a "modified BPP" (CTG + amniotic fluid) or Doppler-led surveillance is more common.